CASC2 and nodular goiter: The lncRNA CASC2 (cancer susceptibility candidate 2) was investigated by Zhou et al. and was found to be under expressed in PTC tissue vs. tissue from patients with nodular goiter, as well as plasma samples from the same patient cohort.